JP Morgan analyst Stephen Tusa downgrades 3M (NYSE:MMM) from Overweight to Neutral and announces $210 price target.
JP Morgan Downgrades 3M to Neutral, Announces $210 Price Target
JP Morgan analyst Stephen Tusa downgrades 3M (NYSE:MMM) from Overweight to Neutral and announces $210 price target.
Related Posts
PMV Pharmaceuticals Q2 EPS $(0.29) Misses $(0.27) Estimate
PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.27) by 7.41 percent.
EngageSmart Reports Partnership With InvoiceCloud, City Of Hagerstown, Maryland, No Terms Disclosed
The City of Hagerstown, MD, has partnered with InvoiceCloud, an EngageSmart ((
JanOne Revises Development Strategy Based On Recent FDA Communications For JAN101; Says ‘The FDA reviewed the data and it provided recommendations and comments on the planned clinical trial to JanOne.’
JanOne Inc. (NASDAQ:JAN), a company that focuses on the development of treatments for conditions that cause severe pain – in conjunction with its continuing focus on the development of drugs with